NCT06892288 · Interventional trial
A Study to Assess the Efficacy and Safety of Weekly Doses of GLM101 in Participants With PMM2-CDG
Overall registry status Active not recruiting
Phase 2 · Phase 3
Conditions PMM2-CDG, Phosphomannomutase 2 Deficiency
Delaware Valley sites
- The Children's Hospital of Philadelphia · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory